Research
Metabolic adaptation
GLP-1 receptor agonists (GLP-1 RAs) may improve obstructive sleep apnea (OSA) symptoms by reducing fat deposition around the upper airway and decreasing systemic inflammation.
Practitioners may consider GLP-1 RAs as a potential treatment option for improving OSA symptoms in obese patients.
StrongSupportsmedium confidence
GLP-1 RAs... have demonstrated substantial efficacy in promoting weight... for their potential to improve OSA symptoms by reducing fat deposition around the upper airway and decreasing systemic inflammation.
Why this rating
The claim is supported by emerging clinical trials mentioned in the abstract.
Source
Current perspectives on the use of GLP-1 receptor agonists in obesity-related obstructive sleep apnea: a narrative review
Ali El-Solh et al. · Expert Opinion on Pharmacotherapy · 2024
reviewCited 21×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →